Las Vegas, NV -- (SBWIRE) -- 12/23/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Vical Incorporated (NASDAQ:VICL), DryShips Inc. (NASDAQ:DRYS), Micron Technology, Inc. (NASDAQ:MU),Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)
Vical Incorporated (NASDAQ:VICL) managed to keep its gain at 5.77% on above-normal volume of 3.71M shares. The stock settled at $1.10 after floating in a range of $1.03 to $1.12. Its latest price has reached market capitalization of $95.46 million. Its 52-week range has been $1.01 to $4.51. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
For How Long VICL will fight for Profitability? Read This Trend Analysis report
DryShips Inc. (NASDAQ:DRYS) traded down/ on a volume of 11.40 million, higher than its standard daily volume. Shares have dropped-1.07% to $3.69. Over the last twelve months, the stock has gained 3.07% and faced a worst price of $1.53. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units.
Has DRYS Found The Bottom And Ready To Gain Momentum? Find Out Here
Micron Technology, Inc. (NASDAQ:MU) settled 2.54% higher at $22.17 on above-normal volume of 49.18M shares during the last trading day. The stock has its 12-month high at $23.67 and 52-week low price was $6.07. It traded in a range of $21.76 to $22.58 during the last trading day. Micron Technology, Inc., is a global manufacturer and marketer of semiconductor devices, principally NAND Flash, DRAM and NOR Flash memory, as well as other memory technologies, packaging solutions and semiconductor systems for use in computing, consumer, networking, automotive, industrial, embedded and mobile products. In addition, the Company manufactures semiconductor components for CMOS images sensors and other semiconductor products.
Why Should Investors Buy MU After the Recent Fall? Just Go Here and Find Out
In the last trading session, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) was up on high volume, trading at a volume of 3.60M shares versus its average daily volume of 169,290.00 shares. At $10.65, the stock has attained market capitalization of $84.14 million. Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides.
Will ORMP Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)